[1]
“Role of Senescence Induced by CDK4/6 Inhibitor Palbociclib in Breast Cancer Treatment Response”, AMAR, vol. 4, no. 3, pp. 697–712, Apr. 2026, doi: 10.5281/zenodo.19384435.